tbc-11251 has been researched along with aliskiren in 2 studies
| Studies (tbc-11251) | Trials (tbc-11251) | Recent Studies (post-2010) (tbc-11251) | Studies (aliskiren) | Trials (aliskiren) | Recent Studies (post-2010) (aliskiren) |
|---|---|---|---|---|---|
| 167 | 32 | 58 | 978 | 211 | 611 |
| Protein | Taxonomy | tbc-11251 (IC50) | aliskiren (IC50) |
|---|---|---|---|
| Renin | Homo sapiens (human) | 0.001 | |
| Renin-1 | Mus musculus (house mouse) | 0.0045 | |
| Renin | Rattus norvegicus (Norway rat) | 0.084 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0004 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.0023 | |
| Renin | Macaca mulatta (Rhesus monkey) | 0.0012 | |
| Renin | Oryctolagus cuniculus (rabbit) | 0.011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bellamy, CO; Dhaun, N; Kluth, DC; MacIntyre, IM | 1 |
1 review(s) available for tbc-11251 and aliskiren
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for tbc-11251 and aliskiren
| Article | Year |
|---|---|
Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.
Topics: Amides; Antihypertensive Agents; Atrophy; Biomarkers; Biopsy; Endothelin Receptor Antagonists; Female; Fibrosis; Fumarates; Humans; Hypertension, Renal; Isoxazoles; Kidney; Middle Aged; Proteinuria; Pulmonary Fibrosis; Renal Insufficiency, Chronic; Renin; Scleroderma, Systemic; Thiophenes; Treatment Outcome | 2009 |